Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Schering AG's Yasmin approved in The Netherlands

June 5, 2000

Enrollment completed in phase III trial of Oxygent

June 5, 2000

Preliminary results reported for Forbes Medi-Tech's new cholesterol-lowering agent

June 5, 2000

Joint research at Novo Nordisk and Dr. Reddy's covered by multiple patents

June 2, 2000

Barr submits IND for Seasonale oral contraceptive

June 2, 2000

Acute effects of MCC-555 on gluconeogenesis in hepatocytes

June 1, 2000

Inhibitor of iNOS attenuates pancreatic beta-cell injury

June 1, 2000

Teijin/TAP gout treatment now also in clinical trials outside Japan

June 1, 2000

Ortho-McNeil describes cyclopropanes with utility in calcium imbalance and metabolism disorders

May 31, 2000

Paladin awarded Canadian distribution rights for testosterone transdermal patch

May 31, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...